Eli Lilly's weight-loss pill Foundayo wins EU regulatory backing
The European Medicines Agency's committee recommended approval of Eli Lilly's oral weight-loss drug Foundayo for obesity and diabetes, following Novo Nordisk's Wegovy as the second oral obesity drug to win the agency's backing.
